Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa
2011

Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa

Sample size: 5494 publication 10 minutes Evidence: moderate

Author Information

Author(s): Westreich Daniel, Cole Stephen R., Nagar Shashi, Maskew Mhairi, van der Horst Charles, Sanne Ian

Primary Institution: Duke Global Health Institute, Duke University

Hypothesis

Pregnancy increases the risk of virologic failure in HIV-positive women receiving HAART.

Conclusion

Incident pregnancy after HAART initiation was associated with modest increases in both relative and absolute risks of virologic failure.

Supporting Evidence

  • Pregnancy was experienced by 541 women in the study.
  • 81 women experienced virologic failure after an incident pregnancy.
  • 94% of women had a suppressed viral load at the time of incident pregnancy.

Takeaway

When women with HIV get pregnant after starting treatment, they might have a harder time keeping the virus under control.

Methodology

A prospective observational cohort study of adult women initiating HAART in Johannesburg, South Africa, followed until an event or administrative end of follow-up.

Potential Biases

Potential detection bias as pregnant women may receive more lab tests than non-pregnant women.

Limitations

Uncontrolled confounding cannot be ruled out, and data on fetal outcomes were not available.

Participant Demographics

The study included 5,494 women, primarily African ethnicity, with a median age of 34 years at HAART initiation.

Statistical Information

P-Value

1.34

Confidence Interval

95% CL 1.02, 1.78

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0022778

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication